ArticleWorld journal of clinical cases2024

Inetetamab combined with tegafur as second-line treatment for human epidermal growth factor receptor-2-positive gastric cancer: A case report.

Jing-Hao Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.